Massachusetts General Hospital
Studies from the United States and United Kingdom add new findings to diabetes body of knowledge
Published in Fitness and Wellness Business Week, May 3rd, 2006
Study 1: Diabetes risk was increased by plasma markers of endothelial dysfunction independent of other diabetes risk factors including obesity, insulin resistance, and inflammation.
"Endothelial dysfunction may precede development of type 2 diabetes. We tested the hypothesis that elevated levels of hemostatic markers of endothelial dysfunction, plasminogen activator inhibitor-1 (PAI-1) antigen, and von Willebrand factor (vWF) antigen predicted incident diabetes independent of other diabetes risk factors," scientists writing in the journal Diabetes...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Fitness and Wellness Business Week
More Articles from Fitness and Wellness Business Week
- AdipoGenix, Inc.
AdipoGenix, Unigen enter agreement to develop plant-based therapeutics targeting fat - Centocor, Inc.
U.S. FDA grants priority review of REMICADE for treatment of pediatric Crohn disease - Cytori Therapeutics, Inc.
Cytori Therapeutics appoints cardiovascular clinical advisory board - Oragenics, Inc.
Oragenics seeks patent for novel agent to treat obesity - Arena Pharmaceutical Research & Development
Selective 5-HT2C agonists show promise in obesity treatments - Beth Israel Deaconess Medical Center, Boston
Researchers from the United States and Japan detail new studies and findings in the area of obesity - More from this issue of Fitness and Wellness Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
